Does RIPRETINIB Cause Therapy interrupted? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Therapy interrupted have been filed in association with RIPRETINIB (QINLOCK). This represents 1.5% of all adverse event reports for RIPRETINIB.
68
Reports of Therapy interrupted with RIPRETINIB
1.5%
of all RIPRETINIB reports
2
Deaths
18
Hospitalizations
How Dangerous Is Therapy interrupted From RIPRETINIB?
Of the 68 reports, 2 (2.9%) resulted in death, 18 (26.5%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which RIPRETINIB Alternatives Have Lower Therapy interrupted Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID